Which Antiplatelet Agent for Patients With TIA and Obesity?

Ticagrelor plus aspirin was associated with a lower risk for recurrent stroke than clopidogrel plus aspirin in patients with obesity who carry the CYP2C19 loss-of-function allele.

Related Keywords

China , United States , South Korea , Beijing , New York , Canada , Chinese , Canadian , Han , Xingquan Zhao , Gregorya Maniatis , National Key Research , Northwell Staten Island University Hospital , Development Program Of China , Departments Of Capital Medical University , Canadian Medical Association Journal , Clopidogrel With Aspirin , High Risk Patients , Acute Nondisabling Cerebrovascular Events , Canadian Medical Association , Beijing Tiantan Hospital , Medscape Medical News , New York City , Chinese Academy , Medical Sciences Innovation Fund , Medical Sciences , Development Program , Training Fund , Open Projects , Clinical Institutes , Capital Medical University , Young Talents , Beijing Medical Management Center The ,